3,688
edits
Neuromuscular Blockade: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
[https://pubmed.ncbi.nlm.nih.gov/36520073/ 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 2023;138:13-41] | [https://pubmed.ncbi.nlm.nih.gov/36520073/ 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 2023;138:13-41] | ||
[https://www.bjaed.org/article/S2058-5349(23)00143-9/fulltext Neuromuscular block management: evidence-based principles and practice] | |||
[https://pubmed.ncbi.nlm.nih.gov/7114542/ Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.] | [https://pubmed.ncbi.nlm.nih.gov/7114542/ Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.] | ||